Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00513435 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
9
Enrollment
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Cancer Institute (NCI)